The prognostic value of tumor-associated carbohydrate structures correlated with gene amplifications in human breast carcinomas

[1]  S. Hirohashi,et al.  Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1. , 1989, Cancer research.

[2]  S. Tsugane,et al.  Prognostic contributions of Helix pomatia and carcinoembryonic antigen staining using histochemical techniques in breast carcinomas. , 1989, Japanese journal of clinical oncology.

[3]  J. Schlom,et al.  Purification and composition of the human tumor-associated glycoprotein (TAG-72) defined by monoclonal antibodies CC49 and B72.3. , 1988, Cancer research.

[4]  S. Hakomori,et al.  Immunoglobulin G3 monoclonal antibody directed to Tn antigen (tumor-associated alpha-N-acetylgalactosaminyl epitope) that does not cross-react with blood group A antigen. , 1988, Cancer research.

[5]  P. Gariglio,et al.  In vivo amplification and rearrangement of c-myc oncogene in human breast tumors. , 1988, Journal of the National Cancer Institute.

[6]  C. Redmond,et al.  Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  S. Hirohashi,et al.  Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope. , 1988, Cancer research.

[8]  J. Klijn,et al.  The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer , 1988, Cancer.

[9]  J. Yokota,et al.  Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer. , 1987, Cancer research.

[10]  L. Liotta,et al.  Role of laminin receptor in tumor cell migration. , 1987, Cancer research.

[11]  J. Yokota,et al.  Proto-oncogene abnormalities in human breast cancer: correlations with anatomic features and clinical course of disease. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  M. Viola.  Proto-oncogene structure and breast cancer prognosis. , 1987, Journal of Clinical Oncology.

[13]  A. Leathem,et al.  PREDICTIVE VALUE OF LECTIN BINDING ON BREAST-CANCER RECURRENCE AND SURVIVAL , 1987, The Lancet.

[14]  K. Griffiths,et al.  Predictive power of progesterone receptor status in early breast carcinoma , 1987, The British journal of surgery.

[15]  M. Castagna,et al.  Mammary cancer antigen recognized by monoclonal antibody B72.3 in apocrine metaplasia of the human breast. , 1987, Cancer research.

[16]  G. Kolata.  Oncogenes give breast cancer prognosis. , 1987, Science.

[17]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[18]  N. Nomura,et al.  Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor , 1986, Nature.

[19]  R. Vihko,et al.  Significance of estrogen and progesterone receptors, disease‐free interval, and site of first metastasis on survival of breast cancer patients , 1985, Cancer.

[20]  I. Taylor,et al.  Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients. , 1984, Cancer research.

[21]  H. Stegner,et al.  Detection of metastatic breast carcinoma cells by immunofluorescent demonstration of thomsen‐friedenreich antigen , 1984, Cancer.

[22]  J. Minna,et al.  Amplification and expression of the c-myc oncogene in human lung cancer cell lines , 1983, Nature.

[23]  J. Dennis,et al.  Different patterns of lectin binding and cell surface sialylation detected on related high- and low-metastatic tumor lines. , 1983, Cancer research.

[24]  G. Nicolson,et al.  Cell surface glycoproteins of 13762NF mammary adenocarcinoma clones of differing metastatic potentials. , 1983, Experimental cell research.

[25]  G. Nicolson.  Cancer metastasis: Organ colonization and the cell-surface properties of mallignant cells , 1982 .

[26]  J. Peto,et al.  Asymptotically Efficient Rank Invariant Test Procedures , 1972 .

[27]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[28]  J. Papadimitriou,et al.  Nuclear DNA content and prognosis in human breast cancer: A static cytophotometric study , 2005, Breast Cancer Research and Treatment.

[29]  G. Auer,et al.  Nuclear DNA Content and Prognosis in Breast Cancer , 1988 .

[30]  J. Russo,et al.  Node-negative breast cancer treated by modified radical mastectomy without adjuvant therapies: variables associated with disease recurrence and survivorship. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  L. Liotta.  Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture. , 1986, Cancer research.

[32]  H. Strander.  Interferon treatment of human neoplasia. , 1986, Advances in cancer research.

[33]  S. Hirohashi,et al.  Carbohydrate antigen defined by a monoclonal antibody raised against a gastric cancer xenograft. , 1985, Japanese journal of cancer research : Gann.

[34]  D.,et al.  Regression Models and Life-Tables , 2022 .